Skip to main content
. 2009 Dec 1;9(3):431–445. doi: 10.1074/mcp.R900002-MCP200

Table II. Yeast organellar proteomics studies.

A summary of the 18 experimental proteomes discussed in this review is given. 2-DE, two-dimensional gel electrophoresis; BAC, N,N′-bisacrylylcystamine; CTAB, cetyltrimethylammonium bromide; GC, gas chromatography; HA, hemagglutinin; nLC, nanoflow LC; LDS, lithium dodecyl sulfate; MudPIT, multidimensional protein identification technology; PFP, peptide fingerprint; RP, reverse-phase; SAX, strong anion exchanger; SCX, strong cation exchanger; WB, Western blot; FFE, free flow electrophoresis; 1D, one-dimensional; 2D, two-dimensional; μLC, microcapillary LC; PMF, peptide mass fingerprint; EC, exchange chromatography; TMDs, transmembrane domains.

Organelle Straina and growth conditionsb Spheroplasting and lysis Purification separation enrichment Stripping Purity assessment Protein and/or peptide separation MS analysis No. of identified proteins (%TMDs) Detected abundance range Validation Ref.
copies/cell
Mitochondria CW04 (n), YPLc Zymolyase; osmotic lysis Differential centrifugation No EM SDS-PAGE nLC-ESI-MS/MS 179 (12%) 149–882,841 GFP or HA tag, computation 27
Mitochondria YPH499 (n), YPGd Zymolyase; mechanical disruption 1) Differential centrifugation, 2) sucrose density gradient (32/60% interface) Salt, shaving with trypsin WB 1) 2-DE, 2) SCX-RP-nLC,e 3) SDS-PAGEe 1) MALDI-MS/MS or nLC-ESI, 2) ESI-MS, 3) nLC-ESI-MS/MS 750 (18%) 99–1,255,722 Protein import assay, presequence 28
Mitochondria BJ1991 (n), YPD versus YPG Zymolyase; mechanical disruption Sucrose density gradient EDTA 2-DE PFP 251 (6%) 149–1,018,216 Transcriptome 34
Mitochondria W303 (n), S1001, YPL, YPD, SCL, and SCDf 1) Nycodenz density gradient, 2) FFE, 3) differential centrifugation Denaturation in 7 m urea, 2 m thiourea, 1% CHAPS EM RP-LC ESI-MS/MS, LC-FTICR 546 (17%) 57–1,255,722 Co-enrichment with known marker using WB 26
Mitochondria YPH499 (n), YPG Zymolyase; mechanical disruption 1) Differential centrifugation, 2) sucrose density gradient (32/60% interface)g EDTA WB 1) 2-DE, 2) SAX- or SCX-RP-LC,e 3) SDS-PAGE 1) MALDI-MS/MS or nLC-ESI, 2) ESI-MS, 3) nLC-ESI-MS/MS 851 (18%) 99–1,255,722 30
Mitochondria YPH499 (n), YPG Zymolyase; mechanical disruption Intact mitochondria as in Ref. 28, Outer membranes: sucrose density gradient (interface 15/32%) EDTA, trypsin WB 1) 2D BAC/SDS, 2) SCX-RP-LC,e 3) SDS-PAGE 1) MALDI-MS/MS, 2) ESI-MS/MS, 3) nLC-ESI-MS/MS 117 (20%) 147–882,841 Computational and biochemical analysis 29
Peroxisomes BJ1991 (n), BJ1991Δpox1, YNOh Lyticase Sucrose density gradient (47–68%) Salt, pH 11.3 1D SDS-PAGE μLC- and nLC-ESI-MS/MS 45 (18%) 358–1,255,722 No 22
Peroxisomes BY4743 (2n), SCIMi Zymolyase; mechanical disruption 1) Differential centrifugation, 2) Nycodenz density gradient (35–50% interface) EDTA μLC GC-ESI-MS/MS 44 (11%) 238–111,935 23
Peroxisomes BY4743 (2n), SCIMi Zymolyase; mechanical disruption 1) Differential centrifugation, 2) Nycodenz density gradient (35–50% interface) pH 11.3 WB ICAT-μLC ESI-MS/MS 72 (21%) 238- 268,717 GFP tagging, mutant phenotype 21
Lipid particles X2180-1A (n), FY1679 (n, 2n), YPD Zymolyase; osmotic lysis Ficoll density gradient Delipidation Enzymatic assays, EM 1D SDS-PAGE nLC-ESI-MS/MS 18 (28%) 1,212–168,876 Lipid and sterol composition in deletion mutants 31
Nucleus BY 4741 (n), YPD Zymolyase; mechanical disruption DNase I, heparin, sucrose density gradient SCX-RP-nLC ESI-MS/MS 2698 (11%) 49–1,255,722 9
Nucleus YPD (Wickerham), BY 4743 (2n) Zymolyase, lyticase, Glucanex; mechanical disruption DNase I, heparin, sucrose density gradient 1) Peptide IEF, 2) SCX-RP-nLC, 3) 1D SDS-PAGE, 4) phosphocellulose chromatography + SDS-PAGE ESI-MS/MS 1889 (5%) 41–1,255,722 10
Golgi CJY119 (n), HIY1 (n), YPD Lyticase; osmotic shock 1) Differential centrifugation, 2) immunoprecipitation Triton X-114 phase separation WB 1D SDS-PAGE MALDI-MS/MS 52 (48%) 238–82,660 Knock-out mutant analysis; HA tagging 6
Vacuolar lumen SEY6210 (n), YPD Zymolyase; mechanical disruption Sucrose/sorbitol/Ficoll density gradient Proteinase K WB, marker enzymes assays, microscopy, flow cytometry 2-DE MALDI-MS/MS, nLC-IT-MS/MS, ESI-MS/MS 118 (5%) 172–1,018,216 Internal 8
Vacuolar membrane W303 (n), YPD Zymolyase, lyticase, Glucanex; osmotic lysis Ficoll density gradient EDTA, pH WB SCX-RP-nLC MALDI-MS/MS 148 (57%) 57–314,034 LOPIT 7
Cell wall FY833 (n), YPD Direct mechanical disruption Differential centrifugation, HF-pyridine extraction Salt, EDTA, SDS, NaOH No information Anion-exchange chromatography nLC-ESI-MS/MS 19 (5%) 600–42,000 Phenotypic cell wall assay using knock-outs 3
Plasma membrane FY1679 (n), YPD, 28 °C Direct mechanical disruption 1) Acid precipitation, 2) sucrose density gradient (34–56%) 0.4% deoxycholate SDS PAGE CTAB/SDS PAGE MALDI-MS/MS 48 (19%) 377–1,255,722 5
Plasma membrane FY1679 (n), YPD Direct mechanical disruption 1) Acid precipitation, 2) Sucrose density gradient (43–53%) EDTA, n-octyl glucoside ATPase assays, SDS-PAGE Anion EC/LDS-PAGE PMF: MALDI-MS, ESI-MS/MS 86 (21%) 166–1,255,722 4

a (n) or (2n) after the strain name indicates haploid or diploid strain, respectively.

b Unless indicated otherwise, the cells were grown aerobically at 30 °C in YPD medium containing 1% yeast extract, 2% Bacto peptone, 2% glucose.

c YPL medium contained 1% yeast extract, 2% Bacto peptone, 0.5% lactic acid.

d YPG medium contained 1% yeast extract, 2% Bacto peptone, 3% glycerol, pH 5.0.

e Digestion was carried out using four proteases: trypsin, chymotrypsin, Glu-C, and subtilisin.

f SCL and SCD media are complete synthetic media supplemented with lactic acid or glucose, respectively.

g YNO contained 0.1% yeast extract, 0.5% ammonium sulfate, 1.7 g/liter yeast nitrogen base, 0.02% Tween 40, 0.3% glucose, 0.1% oleic acid.

h SCIM contained 0.5% yeast extract, 0.1% peptone, 0.79 g/liter complete synthetic medium mixture, 0.5% ammonium sulfate, 1.7 g/liter yeast nitrogen base, 0.1% Tween 40, 0.1% glucose, 0.15% oleic acid.